The next 10 years in interventional cardiology. Interview by Louise Rishton

Gregg Stone is Professor of Medicine at Columbia University, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapies at Columbia University Medical Center, and Co-Director of Medical Education and Research at the Cardiovascular Research Foundation in New York (NY, USA). He has served as the principle investigator for more than 70 national and international multicenter randomized trials, has authored >1000 book chapters, manuscripts and abstracts published in peer-reviewed journals, and has delivered >2000 invited lectures around the world. His areas of expertise include interventional therapies of acute coronary syndromes and myocardial infarction; drug-eluting stents; adjunct pharmacology; new device angioplasty including distal embolic protection, thrombectomy, vascular brachytherapy and stent grafts; intravascular imaging; saphenous vein graft therapies; chronic total occlusions; vulnerable plaque; contrast nephropathy; mitral valve therapies; clinical trial design and regulatory issues. Along with Martin Leon, Stone is the director of Transcatheter Cardiovascular Therapeutics, the world's largest symposium devoted to interventional cardiology and vascular medicine. Stone's medical practice is devoted to interventional cardiology procedures at Columbia University Medical Center.